These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 38815168)

  • 1. Prostate Cancer Foundation Screening Guidelines for Black Men in the United States.
    Garraway IP; Carlsson SV; Nyame YA; Vassy JL; Chilov M; Fleming M; Frencher SK; George DJ; Kibel AS; King SA; Kittles R; Mahal BA; Pettaway CA; Rebbeck T; Rose B; Vince R; Winn RA; Yamoah K; Oh WK
    NEJM Evid; 2024 May; 3(5):EVIDoa2300289. PubMed ID: 38815168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening for prostate cancer.
    Ilic D; Neuberger MM; Djulbegovic M; Dahm P
    Cochrane Database Syst Rev; 2013 Jan; 2013(1):CD004720. PubMed ID: 23440794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physician Consultations, Prostate Cancer Knowledge, and PSA Screening of African American Men in the Era of Shared Decision-Making.
    Woods-Burnham L; Stiel L; Wilson C; Montgomery S; Durán AM; Ruckle HR; Thompson RA; De León M; Casiano CA
    Am J Mens Health; 2018 Jul; 12(4):751-759. PubMed ID: 29658371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate cancer screening practices in a large, integrated health system: 2007-2014.
    Misra-Hebert AD; Hu B; Klein EA; Stephenson A; Taksler GB; Kattan MW; Rothberg MB
    BJU Int; 2017 Aug; 120(2):257-264. PubMed ID: 28139034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do African-American men need separate prostate cancer screening guidelines?
    Shenoy D; Packianathan S; Chen AM; Vijayakumar S
    BMC Urol; 2016 May; 16(1):19. PubMed ID: 27165293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement.
    ; Grossman DC; Curry SJ; Owens DK; Bibbins-Domingo K; Caughey AB; Davidson KW; Doubeni CA; Ebell M; Epling JW; Kemper AR; Krist AH; Kubik M; Landefeld CS; Mangione CM; Silverstein M; Simon MA; Siu AL; Tseng CW
    JAMA; 2018 May; 319(18):1901-1913. PubMed ID: 29801017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Relationship of Baseline Prostate Specific Antigen and Risk of Future Prostate Cancer and Its Variance by Race.
    Verges DP; Dani H; Sterling WA; Weedon J; Atallah W; Mehta K; Schreiber D; Weiss JP; Karanikolas NT
    J Natl Med Assoc; 2017 Spring; 109(1):49-54. PubMed ID: 28259216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate cancer screening with prostate-specific antigen (PSA) test: a systematic review and meta-analysis.
    Ilic D; Djulbegovic M; Jung JH; Hwang EC; Zhou Q; Cleves A; Agoritsas T; Dahm P
    BMJ; 2018 Sep; 362():k3519. PubMed ID: 30185521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baseline Prostate-specific Antigen Level in Midlife and Aggressive Prostate Cancer in Black Men.
    Preston MA; Gerke T; Carlsson SV; Signorello L; Sjoberg DD; Markt SC; Kibel AS; Trinh QD; Steinwandel M; Blot W; Vickers AJ; Lilja H; Mucci LA; Wilson KM
    Eur Urol; 2019 Mar; 75(3):399-407. PubMed ID: 30237027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Racial disparities in prostate cancer survival in a screened population: Reality versus artifact.
    Kaur D; Ulloa-Pérez E; Gulati R; Etzioni R
    Cancer; 2018 Apr; 124(8):1752-1759. PubMed ID: 29370459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate Cancer Incidence and PSA Testing Patterns in Relation to USPSTF Screening Recommendations.
    Jemal A; Fedewa SA; Ma J; Siegel R; Lin CC; Brawley O; Ward EM
    JAMA; 2015 Nov; 314(19):2054-61. PubMed ID: 26575061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Social ecological predictors of prostate-specific antigen blood test and digital rectal examination in black American men.
    Woods VD; Montgomery SB; Herring RP; Gardner RW; Stokols D
    J Natl Med Assoc; 2006 Apr; 98(4):492-504. PubMed ID: 16623061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for Prostate Cancer Starting at Age 50-54 Years. A Population-based Cohort Study.
    Carlsson S; Assel M; Ulmert D; Gerdtsson A; Hugosson J; Vickers A; Lilja H
    Eur Urol; 2017 Jan; 71(1):46-52. PubMed ID: 27084245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for prostate cancer: the current evidence and guidelines controversy.
    Gomella LG; Liu XS; Trabulsi EJ; Kelly WK; Myers R; Showalter T; Dicker A; Wender R
    Can J Urol; 2011 Oct; 18(5):5875-83. PubMed ID: 22018148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Racial disparities in prostate cancer outcome among prostate-specific antigen screening eligible populations in the United States.
    Mahal BA; Chen YW; Muralidhar V; Mahal AR; Choueiri TK; Hoffman KE; Hu JC; Sweeney CJ; Yu JB; Feng FY; Kim SP; Beard CJ; Martin NE; Trinh QD; Nguyen PL
    Ann Oncol; 2017 May; 28(5):1098-1104. PubMed ID: 28453693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Impact of Intensifying Prostate Cancer Screening in Black Men: A Model-Based Analysis.
    Nyame YA; Gulati R; Heijnsdijk EAM; Tsodikov A; Mariotto AB; Gore JL; Etzioni R
    J Natl Cancer Inst; 2021 Oct; 113(10):1336-1342. PubMed ID: 33963850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized trial of community health worker-led decision coaching to promote shared decision-making for prostate cancer screening among Black male patients and their providers.
    Makarov DV; Feuer Z; Ciprut S; Lopez NM; Fagerlin A; Shedlin M; Gold HT; Li H; Lynch G; Warren R; Ubel P; Ravenell JE
    Trials; 2021 Feb; 22(1):128. PubMed ID: 33568208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do racial disparities exist in the use of prostate cancer screening and detection tools in veterans?
    Hudson MA; Luo S; Chrusciel T; Yan Y; Grubb RL; Carson K; Scherrer JF
    Urol Oncol; 2014 Jan; 32(1):34.e9-18. PubMed ID: 23506962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate-specific antigen values at the time of prostate cancer diagnosis in African-American men.
    Moul JW; Sesterhenn IA; Connelly RR; Douglas T; Srivastava S; Mostofi FK; McLeod DG
    JAMA; 1995 Oct; 274(16):1277-81. PubMed ID: 7563532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.